Lyra Therapeutics Inc.

Clinical research activity is centered on chronic rhinosinusitis in adult patients, with attention to persistent sinonasal symptoms and treatment-resistant disease. The trial portfolio reflects interest in CRS without nasal polyps and in patients who have not responded adequately to prior medical management.

• Sinonasal symptom control
• Adult chronic sinusitis
• Non-polypoid CRS

The sponsor’s research focus in this area is tied to improving the core symptom burden of chronic sinus disease and addressing unmet needs in adults with ongoing nasal and sinus inflammation.